Foot News and Research

RSS

BSD-2000 Hyperthermia System purchased by Cancer Treatment Centers of America

BSD Medical Corporation, a leading provider of medical systems that utilize targeted heat therapy to treat cancer, announced today that the Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (WRMC), located in Goodyear, Arizona, has purchased a BSD-2000 Hyperthermia System (BSD-2000).

26 Nov 2012

Bowel cancer and GIST patients could benefit from novel oral drug

Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.

22 Nov 2012

Ankle repair recovery predictors identified

Findings from a cohort study point to factors that may influence the outcome of patients with ankle fractures requiring surgery.

22 Nov 2012

New approach could help orthopaedic surgeons better deal with battlefield injuries

Bones are resilient and heal well after most fractures. But in cases of traumatic injury, in which big pieces of bone are missing, healing is much more difficult, if not impossible. These so-called "large segmental defects" are a major clinical problem, and orthopaedic surgeons struggle to treat them, especially among the military in places like Afghanistan.

22 Nov 2012

Certain mutated cells continue DNA replication process even after drug treatment

Certain mutated cells keep trying to replicate their DNA - with disastrous results - even after medications rob them of the raw materials to do so, according to new research from USC.

21 Nov 2012

Arginine and proline supplementation favor wound healing in diabetic rats

Chronic wounds such as foot ulcers are a common problem for diabetics and are the cause of more than 80 percent of the lower leg amputations in these patients. There is currently no effective way to improve healing of these types of wounds, but new research offers hope.

16 Nov 2012

ACOEM provides tools and resources to help employers manage diabetes

In recognition of November as National Diabetes Month, the American College of Occupational and Environmental Medicine (ACOEM) is providing tools and resources to help employers identify and respond to the impact of diabetes on worker health and productivity.

16 Nov 2012

Diabetic foot reconstruction with free flaps pays dividends

Diabetic foot reconstruction using free flaps has high success and survival rates, say researchers.

15 Nov 2012

Braking mechanism in olfactory neurons helps generate amazing diversity of sensors in the nose

The human nose has millions of olfactory neurons grouped into hundreds of different neuron types. Each of these neuron types expresses only one odorant receptor, and all neurons expressing the same odorant receptor plug into one region in the brain, an organization that allows for specific odors to be sensed.

15 Nov 2012

U.N. has 'moral responsibility' to address cholera outbreak in Haiti

Sometimes "[w]hen the international aid community descends on a vulnerable place ... good intentions make a bad situation even worse," a Boston Globe editorial states, adding that is "what happened two years ago, when United Nations peacekeepers arrived in Haiti in the wake of a devastating earthquake, bringing the deadly disease cholera with them."

14 Nov 2012

ProMedica opens new autism center in Toledo

One in every 88 U.S. children has been diagnosed with autism, according to the Centers for Disease Control and Prevention. To address the critical needs across the nation and in northwest Ohio, ProMedica has opened a new autism center with several area programs and resources under one roof.

14 Nov 2012

Reflexology can help cancer patients manage their symptoms and perform daily tasks

A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology - a type of specialized foot massage practiced since the age of pharaohs - can help cancer patients manage their symptoms and perform daily tasks.

14 Nov 2012

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Plexxikon today announced that updated Phase 1 clinical data of Zelboraf (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los Angeles, CA.

8 Nov 2012

Diabetic foot complication risk highlighted in men

Men should be considered for aggressive treatment for foot complications associated with diabetes, such as ulceration and amputation, say researchers.

8 Nov 2012

New understanding of how noise can break critical tip link protein structure in inner ear cells

Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.

8 Nov 2012

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.

6 Nov 2012

Tornier third quarter 2012 sales increase to $58.0 million

Tornier N.V., a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial results for the third quarter ended September 30, 2012 and updated its fiscal 2012 financial outlook.

6 Nov 2012

Penn Medicine plans to begin second part of expansion project at PPMC campus

Penn Medicine announced today plans to begin the second part of an expansion project that will transform and modernize the advanced care services provided at the Penn Presbyterian Medical Center (PPMC) campus.

4 Nov 2012

Advanced breast cancer that has spread to the brain could be treated with drug combination

The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological side effects of whole brain radiotherapy (WBRT), suggests new research published Online First in The Lancet Oncology.

2 Nov 2012

Club foot ankle osteoarthritis risk revealed

Patients treated for clubfoot have a low long-term risk for ankle osteoarthritis, say Swedish researchers after studying patients aged over 60 years.

1 Nov 2012

Foot News and Research

BSD-2000 Hyperthermia System purchased by Cancer Treatment Centers of America

Bowel cancer and GIST patients could benefit from novel oral drug

Ankle repair recovery predictors identified

New approach could help orthopaedic surgeons better deal with battlefield injuries

Certain mutated cells continue DNA replication process even after drug treatment

Arginine and proline supplementation favor wound healing in diabetic rats

ACOEM provides tools and resources to help employers manage diabetes

Diabetic foot reconstruction with free flaps pays dividends

Braking mechanism in olfactory neurons helps generate amazing diversity of sensors in the nose

U.N. has 'moral responsibility' to address cholera outbreak in Haiti

ProMedica opens new autism center in Toledo

Reflexology can help cancer patients manage their symptoms and perform daily tasks

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Diabetic foot complication risk highlighted in men

New understanding of how noise can break critical tip link protein structure in inner ear cells

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

Tornier third quarter 2012 sales increase to $58.0 million

Penn Medicine plans to begin second part of expansion project at PPMC campus

Advanced breast cancer that has spread to the brain could be treated with drug combination

Club foot ankle osteoarthritis risk revealed

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News